top of page

History

2022
2023
2020
2019
2017
2016
2015

• 510(K) cleared for Gen II, Neuroblade System

• Series B fund raising

• 510(K) cleared for Axonpen System

​

• Start FIM clinical trial in Chang Gang Memorial Hospital in Taiwan

• Series A fund raising

• Cadaver feasibility study completed

• Animal feasibility study completed

• Founded by Dr. Abel Huang in San Francisco, US by pitching to Y Combinator

​

• Seed round  fund raising

History-1.jpg
History-2.jpg
Histpry-3.jpg
bottom of page